img Leseprobe Leseprobe

Unhealthy Politics

The Battle over Evidence-Based Medicine

Eric M. Patashnik, Conor M. Dowling, Alan S. Gerber

PDF
ca. 28,99
Amazon iTunes Thalia.de Weltbild.de Hugendubel Bücher.de ebook.de kobo Osiander Google Books Barnes&Noble bol.com Legimi yourbook.shop Kulturkaufhaus ebooks-center.de
* Affiliatelinks/Werbelinks
Hinweis: Affiliatelinks/Werbelinks
Links auf reinlesen.de sind sogenannte Affiliate-Links. Wenn du auf so einen Affiliate-Link klickst und über diesen Link einkaufst, bekommt reinlesen.de von dem betreffenden Online-Shop oder Anbieter eine Provision. Für dich verändert sich der Preis nicht.

Princeton University Press img Link Publisher

Sozialwissenschaften, Recht, Wirtschaft / Politikwissenschaft

Beschreibung

How partisanship, polarization, and medical authority stand in the way of evidence-based medicine

The U.S. medical system is touted as the most advanced in the world, yet many common treatments are not based on sound science. Unhealthy Politics sheds new light on why the government's response to this troubling situation has been so inadequate, and why efforts to improve the evidence base of U.S. medicine continue to cause so much political controversy. This critically important book paints a portrait of a medical industry with vast influence over which procedures and treatments get adopted, and a public burdened by the rising costs of health care yet fearful of going against "doctor's orders." Now with a new preface by the authors, Unhealthy Politics offers vital insights into the limits of science, expertise, and professionalism in American politics.

Kundenbewertungen

Schlagwörter

Health economics, Prostate cancer, Good government, Politician, Health insurance, Sham surgery, Trust Doctor, Tax, Election, Pathology, Outcomes research, Sustainability, Prescription drug, Cardiology, Medical education, Pharmaceutical drug, Patient Protection and Affordable Care Act, Cost-effectiveness analysis, Inefficiency, Surgery, Funding, Doctor–patient relationship, Symptom, Clinician, Trade association, Medical error, Indication (medicine), Medical research, Specialty (medicine), Health care reform, Insurance, Healthcare industry, Voting, Comparative effectiveness research, Welfare, Pharmaceutical industry, Medical device, Political science, Breast cancer, Cardiovascular disease, Effectiveness, Payment, Physician, Advocacy group, Prostate-specific antigen, Public policy, Medicaid, Politics, Entrepreneurship, Rationing, Health technology, Skepticism, Health care in the United States, Health Affairs, Malpractice, Clinical trial, Complication (medicine), Medical procedure, Governance, Yale University, Disease, Efficacy, Health care, American Recovery and Reinvestment Act of 2009, Health policy, Legislation, Independent Payment Advisory Board, Guideline, Reimbursement, Health system